JPRN-UMIN000000781
Completed
Phase 2
Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancer - CBDCA+GEM vs TS1+DTX phase II trial for completely resected lung cancer
Japanese Northern East Area Thoracic Surgery Study Group0 sites120 target enrollmentAugust 1, 2007
Conditionsnon-small cell lung cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- non-small cell lung cancer
- Sponsor
- Japanese Northern East Area Thoracic Surgery Study Group
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •symptomatic interstitial pneumonia multiple lung cancer or other\-type cancer within 5 years severe organ failure past history of radiotherapy or chemotherapy pregnant or expecting mother
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Randomized phase II trial of adjuvant chemotherapy with vinorelbine plus cisplatin versus S-1 plus carboplatin in patients with completely resected stage II/IIIA non-small cell lung canceron-small cell lung cancerJPRN-UMIN000008165Fukushima medical University Hospital60
Active, not recruiting
Phase 2
Randomized Phase II study of adjuvant chemotherapy with GC versus GS in patients with BTC undergoing curative resection without major hepatectomybiliary tract cancerBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-jRCTs051190040Yanagimoto Hiroaki106
Completed
Phase 2
Randomized Phase II study of adjuvant chemotherapy with gemcitabine plus cisplatin versus gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy(KHBO1901)biliary tract cancerJPRN-UMIN000036449Kansai Hepatobiliary Oncology Group (KHBO)106
Active, not recruiting
Not Applicable
Randomized phase II study of adjuvant chemotherapy with cisplatin + vinorelbine vs gemcitabine + vinorelbine in stage IB-IIIA radically resected non-small cell lung cancer (NSCLC) patients - MADSnon-small cell lung cancer (NSCLC)MedDRA version: 9.1Level: LLTClassification code 10061873Term: Non-small cell lung cancerEUCTR2008-000570-21-ITIST - ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO
Not yet recruiting
Not Applicable
Randomized Phase 2 study of Adjuvant Chemotherapy vs Observation After Complete Resection of Stage III Soft Tissue SarcomasNeoplasmsKCT0008321ational Cancer Center98